Efficacy and Safety of AXS-05, an Oral NMDA Receptor Antagonist With Multimodal Activity, in Major Depressive Disorder: Results From the GEMINI Trial

Authors
Category Primary study
JournalAnnals of Clinical Psychiatry
Year 2021
This article has no abstract
Epistemonikos ID: 1532aa2de3e372ec484b504afae46a22def634d8
First added on: Feb 14, 2025